FindTrial
Sign In

Pharmacokinetics of Triphala Guggulu

Pharmaceutico-Analytical And Drug Disposition Study of Triphala Guggulu

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/046987
Enrollment
6
Registered
2022-11-02
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Dr Neelam Rawat
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All Age Groups Healthy Volunteers willing to sign Informed consent form (ICF)

Exclusion criteria

Exclusion criteria: Any serious medical & seriously ill patients. Volunteers on any previous medication. Volunteers consuming alcohol, chewing tobacco and cigarette smoking.

Design outcomes

Primary

MeasureTime frame
1. To analyse the disintegration of Guggulu Tablet at regular intervals of 2,4,8 and 24 hrs. 2.To analyse the disintegration of Triphala Guggulu Tablet at regular intervals of 2,4,8 and 24 hrs.Timepoint: 24 hrs—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Neelam Rawat

Uttarakhand Ayurved University Rishikul Campus Uttarakhand Haridwar

drkhemchand.sharma@gmail.com8006945015

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026